(PharmaNewsWire.Com, July 05, 2017 ) Merkel cell carcinoma is a rare aggressive skin cancer that is at high risk of recurring and spreading (metastasizing) throughout the body. Risk factors for Merkel cell carcinoma include age, gender, light skin color, Ultraviolet exposure and immune suppression....
(PharmaNewsWire.Com, July 05, 2017 ) Sjogren's syndrome is an autoimmune disease. It involves inflammation of glands and other tissues of the body. Symptoms include skin rashes or dry skin, vaginal dryness, persistent dry cough, prolonged fatigue, dry eye, dry mouth, joint pain, swelling and stiffness....
(PharmaNewsWire.Com, July 05, 2017 ) Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. GBMs arise from glial cells, which are cells that form the tissue that surrounds and protects other nerve cells found within the brain and spinal cord. GBMs are mainly composed of...
(PharmaNewsWire.Com, July 05, 2017 ) Cushing disease is a condition in which the pituitary gland releases too much adrenocorticotropic hormone (ACTH) . Symptoms include acne or skin infections, backache, mental changes, such as depression, anxiety, or changes in behavior. Treatment includes surgery...
(PharmaNewsWire.Com, July 05, 2017 ) The Global Healthcare Scanners Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Healthcare Scanners industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply...
(PharmaNewsWire.Com, July 05, 2017 ) "According to Publisher, the Global Autonomous Underwater Vehicles Market is accounted for $190.56 million in 2015 and is expected to reach $505.23 million by 2022 growing at a CAGR of 14.9% during the forecast period". Increased adoption of autonomous underwater...
(PharmaNewsWire.Com, July 05, 2017 ) "According to Publisher, the Global Automotive Reconfigurable Instrument Cluster Market is expected to grow at a CAGR of 17.2% during the forecast period". Factors such as reconfiguration needs from consumer electronics and declining prices of LCD display are...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hirsutism-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hirsutism. The Publisher's Report covers the product profiles in various stages of development including Discovery,...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Herpetic Keratitis-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Herpetic Keratitis. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hereditary Angioedema (HAE)-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hereditary Angioedema (HAE). The Publisher's Report covers the product profiles in various...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hepatitis A-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis A. The Publisher's Report covers the product profiles in various stages of development including...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hepatic Edema-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hepatic Edema. The Publisher's Report covers the product profiles in various stages of development including...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hepatic - Colorectal Metastasis-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hepatic - Colorectal Metastasis. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hemorrhagic Shock-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hemorrhagic Shock. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, July 05, 2017 ) Publisher's, "Hemolytic Uremic Syndrome-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hemolytic Uremic Syndrome. The Publisher's Report covers the product profiles in various stages...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
